RTOG 0825: PRIMARY OUTCOME RESULTS FROM A PHASE III RANDOMIZED, PLACEBO CONTROLLED TRIAL EVALUATING BEVACIZUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA Conference

Gilbert, Mark, Pugh, Stephanie, Won, Minhee et al. (2013). RTOG 0825: PRIMARY OUTCOME RESULTS FROM A PHASE III RANDOMIZED, PLACEBO CONTROLLED TRIAL EVALUATING BEVACIZUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA . NEURO-ONCOLOGY, 15 109-109.

International Collaboration

cited authors

  • Gilbert, Mark; Pugh, Stephanie; Won, Minhee; Blumenthal, Deborah; Vogelbaum, Michael; Aldape, Ken; Colman, Howard; Chakravarti, Arnab; Jeraj, Robert; Dignam, James; Armstrong, Terri; Wefel, Jeffrey; Brown, Paul; Jaeckle, Kurt; Schiff, David; Brachman, David; Werner-Wasik, Maria; Tremont-Lukats, Ivo; Sulman, Erik; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 21, 2013 -

publication date

  • November 1, 2013

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • San Francisco, CA

Conference

  • 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 109

end page

  • 109

volume

  • 15